Triple

T15982941
Position Surface form Disambiguated ID Type / Status
Subject Ariad Pharmaceuticals E387618 entity
Predicate acquiredBy P347 FINISHED
Object Takeda Pharmaceutical Company E474950 NE FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Takeda Pharmaceutical Company | Statement: [Ariad Pharmaceuticals, acquiredBy, Takeda Pharmaceutical Company]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Takeda Pharmaceutical Company
Context triple: [Ariad Pharmaceuticals, acquiredBy, Takeda Pharmaceutical Company]
  • A. Takeda Pharmaceutical Company chosen
    Takeda Pharmaceutical Company is a leading global biopharmaceutical firm headquartered in Japan, focused on developing innovative medicines in areas such as oncology, gastroenterology, neuroscience, and rare diseases.
  • B. Daiichi Sankyo
    Daiichi Sankyo is a major Japanese global pharmaceutical company known for developing innovative medicines, particularly in cardiovascular disease and oncology.
  • C. Chugai Pharmaceutical
    Chugai Pharmaceutical is a major Japanese research-based pharmaceutical company known for its innovative biopharmaceuticals and strategic alliance with Roche.
  • D. Mitsubishi Tanabe Pharma
    Mitsubishi Tanabe Pharma is a Japanese pharmaceutical company known for developing prescription drugs and biopharmaceuticals, including treatments for neurological and autoimmune diseases.
  • E. Eisai
    Eisai is a Japanese pharmaceutical company known for developing treatments in neurology and oncology, including Alzheimer’s disease therapies.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d86da94ccc819083d187f5dc6a123e completed April 10, 2026, 3:25 a.m.
NER Named-entity recognition batch_69e15755b5548190acfa29eecb11e675 completed April 16, 2026, 9:40 p.m.
NED1 Entity disambiguation (via context triple) batch_69ffc3cdf7848190848e9081027dc027 completed May 9, 2026, 11:31 p.m.
Created at: April 10, 2026, 4:54 a.m.